Arvinas Inc (ARVN)
34.95
+0.23
(+0.66%)
USD |
NASDAQ |
Apr 22, 16:00
34.93
-0.02
(-0.06%)
After-Hours: 20:00
Arvinas Market Cap: 2.380B for April 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 2.380B |
| April 19, 2024 | 2.364B |
| April 18, 2024 | 2.335B |
| April 17, 2024 | 2.277B |
| April 16, 2024 | 2.277B |
| April 15, 2024 | 2.364B |
| April 12, 2024 | 2.471B |
| April 11, 2024 | 2.537B |
| April 10, 2024 | 2.501B |
| April 09, 2024 | 2.593B |
| April 08, 2024 | 2.563B |
| April 05, 2024 | 2.549B |
| April 04, 2024 | 2.580B |
| April 03, 2024 | 2.627B |
| April 02, 2024 | 2.658B |
| April 01, 2024 | 2.751B |
| March 28, 2024 | 2.811B |
| March 27, 2024 | 2.814B |
| March 26, 2024 | 2.791B |
| March 25, 2024 | 2.769B |
| March 22, 2024 | 2.853B |
| March 21, 2024 | 2.951B |
| March 20, 2024 | 3.007B |
| March 19, 2024 | 2.898B |
| March 18, 2024 | 2.900B |
| Date | Value |
|---|---|
| March 15, 2024 | 3.054B |
| March 14, 2024 | 3.045B |
| March 13, 2024 | 3.165B |
| March 12, 2024 | 3.096B |
| March 11, 2024 | 3.098B |
| March 08, 2024 | 3.203B |
| March 07, 2024 | 3.246B |
| March 06, 2024 | 3.131B |
| March 05, 2024 | 3.180B |
| March 04, 2024 | 3.164B |
| March 01, 2024 | 3.220B |
| February 29, 2024 | 3.130B |
| February 28, 2024 | 3.128B |
| February 27, 2024 | 3.269B |
| February 26, 2024 | 3.322B |
| February 23, 2024 | 3.200B |
| February 22, 2024 | 3.167B |
| February 21, 2024 | 3.248B |
| February 20, 2024 | 3.445B |
| February 16, 2024 | 3.557B |
| February 15, 2024 | 3.531B |
| February 14, 2024 | 3.357B |
| February 13, 2024 | 3.248B |
| February 12, 2024 | 3.480B |
| February 09, 2024 | 3.393B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
509.05M
Minimum
Oct 18 2019
5.298B
Maximum
Jul 29 2021
2.238B
Average
1.956B
Median
Jan 23 2020
Market Cap Benchmarks
| Pfizer Inc | 148.28B |
| Bristol-Myers Squibb Co | 99.37B |
| Janux Therapeutics Inc | 2.525B |
| Geron Corp | 2.037B |
| Verastem Inc | 245.48M |
Market Cap Related Metrics
| PS Ratio | 24.71 |
| PEG Ratio | -0.2424 |
| Price to Book Value | 3.605 |
| Price | 34.95 |
| Earnings Yield | -18.60% |
| PEGY Ratio | -0.2424 |